← All companies

PROK

ProKidney Corp.

PROK Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$1.56

+0.02 +1.30%

Key statistics

from XBRL data in SEC filings

Market cap

$96.0M

Revenue (TTM)

$889K

Net income (TTM)

-$72.3M

EPS (TTM)

$-0.23

P/E ratio

—

Dividend yield

—

Free cash flow

-$135M

Cash

$102M

Total assets

$293M

Gross margin

—

52-week range

$1.45 – $3.48

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results May 29, 2026 8-K Results of operations (earnings release); Regulation FD disclosure; Other events May 15, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Results of operations (earnings release) Mar 18, 2026 10-K Fiscal year ended 2025-12-31 Mar 18, 2026 8-K Regulation FD disclosure; Other events Feb 2, 2026 8-K Regulation FD disclosure Jan 12, 2026 8-K Results of operations (earnings release) Nov 10, 2025 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Entered a material agreement Oct 17, 2025 8-K Results of operations (earnings release) Aug 12, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Regulation FD disclosure; Other events Jul 15, 2025 8-K Entered a material agreement; Terminated a material agreement; Other events Jul 14, 2025 8-K Regulation FD disclosure Jul 8, 2025 8-K Regulation FD disclosure Jul 1, 2025 8-K Shareholder vote results; Regulation FD disclosure May 30, 2025 8-K Results of operations (earnings release) May 12, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 10-K Fiscal year ended 2024-12-31 Mar 17, 2025 8-K Results of operations (earnings release) Mar 17, 2025 8-K Entered a material agreement Jan 21, 2025 8-K Entered a material agreement Nov 22, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Regulation FD disclosure; Other events Sep 3, 2024 10-Q Quarter ended 2024-06-30 Aug 9, 2024 8-K Results of operations (earnings release) Aug 9, 2024 8-K Entered a material agreement; Other events Jun 13, 2024 8-K Regulation FD disclosure; Other events Jun 10, 2024 8-K Shareholder vote results May 31, 2024 8-K Regulation FD disclosure May 29, 2024 10-Q Quarter ended 2024-03-31 May 10, 2024 8-K Results of operations (earnings release) May 10, 2024 8-K Director or officer change; Regulation FD disclosure Mar 25, 2024 8-K Results of operations (earnings release) Mar 22, 2024 10-K Fiscal year ended 2023-12-31 Mar 22, 2024 8-K/A Director or officer change Mar 18, 2024 8-K/A Director or officer change Mar 18, 2024 8-K Director or officer change Feb 12, 2024